FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36384011000001106: Ondansetron 8mg tablets (Cipla EU Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111326201000001113 Ondansetron 8mg tablets (Cipla EU Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111326301000001116 Ondansetron 8mg tablets (Cipla EU Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 8mg tablets (Cipla EU Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Is a Ondansetron 8mg tablets true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Is a Ondansetron 8mg tablets false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Is a Product containing precisely ondansetron 8 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has presentation strength numerator value 8 false Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has precise active ingredient Ondansetron true Inferred relationship Existential restriction modifier 1
Ondansetron 8mg tablets (Cipla EU Ltd) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 8mg tablets (Cipla EU Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 8mg tablets (Cipla EU Ltd) 10 tablet Has AMP True Ondansetron 8mg tablets (Cipla EU Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start